About Us - Company
Sareum is an experienced and specialist cancer drug discovery company. Sareum has a highly experienced team with a track record of delivering high quality drug candiates for pharmaceutical and biotechnology companies.
Sareum is developing a robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies.
Sareum is a public listed company and its shares are listed on the AIM market of the London Stock Exchange.
Requires RSS news reader
Requires MS Word
Requires Adobe Acrobat Reader